These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24390152)

  • 1. Mechanisms underlying the neuroprotective effect of brain reserve against late life depression.
    Freret T; Gaudreau P; Schumann-Bard P; Billard JM; Popa-Wagner A
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S55-61. PubMed ID: 24390152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.
    Licznerski P; Duman RS
    Neuroscience; 2013 Oct; 251():33-50. PubMed ID: 23036622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuroprotective effects of estrogen on the aging brain.
    Norbury R; Cutter WJ; Compton J; Robertson DM; Craig M; Whitehead M; Murphy DG
    Exp Gerontol; 2003; 38(1-2):109-17. PubMed ID: 12543268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
    Pham TH; Gardier AM
    Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3β/β-catenin signaling.
    Garza JC; Guo M; Zhang W; Lu XY
    Mol Psychiatry; 2012 Jul; 17(8):790-808. PubMed ID: 22182938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiological and clinical effects of the antidepressant tianeptine.
    Kasper S; McEwen BS
    CNS Drugs; 2008; 22(1):15-26. PubMed ID: 18072812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice.
    Higuchi F; Uchida S; Yamagata H; Abe-Higuchi N; Hobara T; Hara K; Kobayashi A; Shintaku T; Itoh Y; Suzuki T; Watanabe Y
    J Neurosci; 2016 Jul; 36(27):7253-67. PubMed ID: 27383599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Ketamine Treatment Promotes Resilience to Chronic Stress and Accelerates Recovery: Correlation with Changes in Synaptic Plasticity in the CA3 Subregion of the Hippocampus.
    Krzystyniak A; Baczynska E; Magnowska M; Antoniuk S; Roszkowska M; Zareba-Koziol M; Das N; Basu S; Pikula M; Wlodarczyk J
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing brain performance: Identifying mechanisms of adaptive neurobiological plasticity.
    Lambert K; Eisch AJ; Galea LAM; Kempermann G; Merzenich M
    Neurosci Biobehav Rev; 2019 Oct; 105():60-71. PubMed ID: 31356835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical activity and brain plasticity in late adulthood.
    Erickson KI; Gildengers AG; Butters MA
    Dialogues Clin Neurosci; 2013 Mar; 15(1):99-108. PubMed ID: 23576893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel GSK-3β inhibitor YQ138 prevents neuronal injury induced by glutamate and brain ischemia through activation of the Nrf2 signaling pathway.
    Pang T; Wang YJ; Gao YX; Xu Y; Li Q; Zhou YB; Xu L; Huang ZJ; Liao H; Zhang LY; Gao JR; Ye Q; Li J
    Acta Pharmacol Sin; 2016 Jun; 37(6):741-52. PubMed ID: 27108601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature.
    Costemale-Lacoste JF; Guilloux JP; Gaillard R
    Encephale; 2016 Apr; 42(2):156-64. PubMed ID: 26995153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic depression as a model disease for cerebral aging.
    Bewernick BH; Schlaepfer TE
    Dialogues Clin Neurosci; 2013 Mar; 15(1):77-85. PubMed ID: 23576891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glycogen synthase kinase-3β in ketamine-induced developmental neuroapoptosis in rats.
    Liu JR; Baek C; Han XH; Shoureshi P; Soriano SG
    Br J Anaesth; 2013 Jun; 110 Suppl 1():i3-9. PubMed ID: 23533250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.
    Masi G; Brovedani P
    CNS Drugs; 2011 Nov; 25(11):913-31. PubMed ID: 22054117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of cerium oxide nanoparticles on experimental stress-induced depression in male rats.
    Zavvari F; Nahavandi A; Shahbazi A
    J Chem Neuroanat; 2020 Jul; 106():101799. PubMed ID: 32371049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of indole-3-carbinol on clonidine-induced neurotoxicity in rats: Impact on oxidative stress, inflammation, apoptosis and monoamine levels.
    El-Naga RN; Ahmed HI; Abd Al Haleem EN
    Neurotoxicology; 2014 Sep; 44():48-57. PubMed ID: 24877722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside-Rg1 Rescues Stress-Induced Depression-Like Behaviors via Suppression of Oxidative Stress and Neural Inflammation in Rats.
    Li Y; Wang L; Wang P; Fan C; Zhang P; Shen J; Yu SY
    Oxid Med Cell Longev; 2020; 2020():2325391. PubMed ID: 32273940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depression and neuroplasticity].
    Pitchot W; Polis M; Belachew S; Ansseau M
    Rev Med Liege; 2008; 63(5-6):372-7. PubMed ID: 18669207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.